Behavioral change challenges in limiting fluoroquinolone and extended-spectrum cephalosporins to prevent Clostridioides difficile disease

Christopher J Graber^{1

2}

Affiliations

¹ Infectious Diseases Section, Veterans' Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
² David Geffen School of Medicine, University of California, Los Angeles, California.

Comment

Christopher J Graber. Infect Control Hosp Epidemiol. 2020 Oct.

. 2020 Oct;41(10):1194-1195.

doi: 10.1017/ice.2020.289. Epub 2020 Aug 7.

Christopher J Graber^{1

2}

¹ Infectious Diseases Section, Veterans' Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
² David Geffen School of Medicine, University of California, Los Angeles, California.

No abstract available

Comment on

Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and Clostridioides difficile infection.
Szymczak JE, Muller BM, Shakamuri NS, Hamilton KW, Gerber JS, Laguio-Vila M, Dumyati GK, Fridkin SK, Guh AY, Reddy SC, Lautenbach E; CDC Prevention Epicenters Program. Szymczak JE, et al. Infect Control Hosp Epidemiol. 2020 Aug;41(8):914-920. doi: 10.1017/ice.2020.183. Epub 2020 May 29. Infect Control Hosp Epidemiol. 2020. PMID: 32468967